Published in J Virol on January 21, 2009
Epstein-Barr virus and systemic lupus erythematosus. Clin Dev Immunol (2012) 0.95
Improper tagging of the non-essential small capsid protein VP26 impairs nuclear capsid egress of herpes simplex virus. PLoS One (2012) 0.92
A beta-herpesvirus with fluorescent capsids to study transport in living cells. PLoS One (2012) 0.84
Molecular interactions of Epstein-Barr virus capsid proteins. J Virol (2010) 0.84
Interactions of the Kaposi's Sarcoma-associated herpesvirus nuclear egress complex: ORF69 is a potent factor for remodeling cellular membranes. J Virol (2013) 0.84
DNA methyltransferase DNMT3A associates with viral proteins and impacts HSV-1 infection. Proteomics (2015) 0.81
The assembly domain of the small capsid protein of Kaposi's sarcoma-associated herpesvirus. J Virol (2012) 0.78
A hydrophobic domain within the small capsid protein of Kaposi's sarcoma-associated herpesvirus is required for assembly. J Gen Virol (2014) 0.78
BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteins. J Virol (2014) 0.78
Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies. J Virol (2015) 0.78
Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase. Exp Biol Med (Maywood) (2014) 0.77
CryoEM and mutagenesis reveal that the smallest capsid protein cements and stabilizes Kaposi's sarcoma-associated herpesvirus capsid. Proc Natl Acad Sci U S A (2015) 0.77
A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. J Transl Med (2015) 0.76
Epstein-Barr virus glycoprotein gM can interact with the cellular protein p32 and knockdown of p32 impairs virus. Virology (2016) 0.75
Herpes Simplex Virus 1 Small Capsomere-Interacting Protein VP26 Regulates Nucleocapsid Maturation. J Virol (2017) 0.75
A short amino acid sequence able to specify nuclear location. Cell (1984) 21.17
Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2. J Virol (1972) 11.71
Sequence requirements for synthetic peptide-mediated translocation to the nucleus. Mol Cell Biol (1989) 4.57
Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J Virol (1998) 3.94
Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol (1994) 3.24
The herpes simplex virus procapsid: structure, conformational changes upon maturation, and roles of the triplex proteins VP19c and VP23 in assembly. J Mol Biol (1996) 3.20
Capsid assembly and DNA packaging in herpes simplex virus. Rev Med Virol (1997) 3.15
Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A (2004) 3.11
Assembly of the herpes simplex virus capsid: characterization of intermediates observed during cell-free capsid formation. J Mol Biol (1996) 2.92
The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol Cell Biol (1999) 2.90
The product of the herpes simplex virus type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA. J Virol (1998) 2.81
Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. J Virol (1993) 2.79
Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene (2003) 2.72
Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. J Gen Virol (1994) 2.69
The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth. J Virol (1994) 2.61
Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids. Virology (1984) 2.35
Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol (2000) 2.34
Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins. J Gen Virol (1996) 1.96
Isolation of herpes simplex virus procapsids from cells infected with a protease-deficient mutant virus. J Virol (2000) 1.90
Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. J Virol (1999) 1.79
Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a. J Gen Virol (1994) 1.73
Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol (2003) 1.54
Assembly of the herpes simplex virus capsid: preformed triplexes bind to the nascent capsid. J Virol (1998) 1.50
The 25 amino acid residues at the carboxy terminus of the herpes simplex virus type 1 UL26.5 protein are required for the formation of the capsid shell around the scaffold. J Gen Virol (1995) 1.45
Evidence for controlled incorporation of herpes simplex virus type 1 UL26 protease into capsids. J Virol (2000) 1.43
Genetic evidence of an essential role for cytomegalovirus small capsid protein in viral growth. J Virol (2001) 1.43
Molecular interactions between the HSV-1 capsid proteins as measured by the yeast two-hybrid system. Virology (1996) 1.39
Packaging-competent capsids of a herpes simplex virus temperature-sensitive mutant have properties similar to those of in vitro-assembled procapsids. J Virol (1999) 1.36
Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog (2008) 1.20
Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol (2007) 1.18
Functional analysis of the triplex proteins (VP19C and VP23) of herpes simplex virus type 1. J Virol (2006) 1.15
Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol (2008) 1.13
Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med (2004) 1.12
Residues of VP26 of herpes simplex virus type 1 that are required for its interaction with capsids. J Virol (2003) 1.08
Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids. J Virol (2008) 1.04
Conventional and immunoelectron microscopy of mitochondria. Methods Mol Biol (2007) 1.04
Mutational analysis of the herpes simplex virus triplex protein VP19C. J Virol (2006) 1.01
Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase. J Virol (1995) 0.96
Structural features of the scaffold interaction domain at the N terminus of the major capsid protein (VP5) of herpes simplex virus type 1. J Virol (2007) 0.89
Assembly of Marek's disease virus (MDV) capsids using recombinant baculoviruses expressing MDV capsid proteins. J Gen Virol (2004) 0.84
Three-dimensional structure of herpes simplex virus from cryo-electron tomography. Science (2003) 3.82
Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol (2005) 3.75
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension (2004) 3.51
Piwi induces piRNA-guided transcriptional silencing and establishment of a repressive chromatin state. Genes Dev (2013) 2.34
CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. J Infect Dis (2012) 1.44
Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe (2011) 1.43
Interaction between Epsin/Yap180 adaptors and the scaffolds Ede1/Pan1 is required for endocytosis. Mol Biol Cell (2008) 1.23
Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J Virol (2009) 1.21
Functional analysis of the triplex proteins (VP19C and VP23) of herpes simplex virus type 1. J Virol (2006) 1.15
A role for heparan sulfate in viral surfing. Biochem Biophys Res Commun (2009) 1.15
Asymmetric enrichment of PIE-1 in the Caenorhabditis elegans zygote mediated by binary counterdiffusion. J Cell Biol (2009) 1.11
Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids. J Virol (2008) 1.04
KSHV regulation of fibulin-2 in Kaposi's sarcoma: implications for tumorigenesis. Am J Pathol (2011) 0.92
MEX-5 enrichment in the C. elegans early embryo mediated by differential diffusion. Development (2010) 0.90
Structural features of the scaffold interaction domain at the N terminus of the major capsid protein (VP5) of herpes simplex virus type 1. J Virol (2007) 0.89
Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits. Bioorg Med Chem (2008) 0.88
Herpes simplex virus 1 protein UL37 interacts with viral glycoprotein gK and membrane protein UL20 and functions in cytoplasmic virion envelopment. J Virol (2014) 0.87
KSHV downregulation of galectin-3 in Kaposi's sarcoma. Glycobiology (2009) 0.85
Bioactive rearranged and halogenated semisynthetic derivatives of the marine natural product sarcophine. J Nat Prod (2004) 0.82
Homology modeling of falcipain-2: validation, de novo ligand design and synthesis of novel inhibitors. J Biomol Struct Dyn (2002) 0.82
CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists. J Mol Model (2002) 0.82
Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results. Radiother Oncol (2009) 0.81
The mitochondrial fission adaptors Caf4 and Mdv1 are not functionally equivalent. PLoS One (2012) 0.81
Staphylococcal enterotoxin A induces small clusters of HLA-DR1 on B cells. PLoS One (2009) 0.80
Mechanism of action of L-arginine on the vitality of spermatozoa is primarily through increased biosynthesis of nitric oxide. Biol Reprod (2006) 0.78
Targeting the BH3 domain mediated protein-protein interaction of Bcl-xL through virtual screening. J Chem Inf Model (2010) 0.78
Computational approaches for the discovery of cysteine protease inhibitors against malaria and SARS. Curr Comput Aided Drug Des (2010) 0.76
The N terminus of the herpes simplex virus type 1 triplex protein, VP19C, cannot be detected on the surface of the capsid shell by using an antibody (hemagglutinin) epitope tag. J Virol (2007) 0.76
VirD: a virion display array for profiling functional membrane proteins. Anal Chem (2013) 0.76
Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. J Chem Inf Model (2011) 0.75
Comparison of primary radiation versus robotic surgery plus adjuvant radiation in high-risk prostate cancer: a single center experience. J Cancer Res Ther (2015) 0.75
Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis. J Cancer Res Ther (2014) 0.75